Fresenius | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
Akzo Nobel EUR 892M 80M 2024-12
Alcon AG USD 802M 7M 2024-12
AstraZeneca USD 5.55B 307M 2024-12
BASF EUR 2.52B 108M 2024-09
Bayer EUR 4.34B 610M 2024-12
Beiersdorf EUR 2B 58M 2024-12
DaVita Healthcare Partners USD 414.48M 20.95M 2024-12
Demant DKK 5.63B 2.77B 2024-12
E.ON EUR 1.68B 94M 2024-09
Essilor EUR 3.17B 103.5M 2024-12
Fresenius EUR 769M 68M 2024-12
Fresenius Medical Care EUR 840M 84M 2024-12
Getinge SEK 2.65B 452M 2024-12
Givaudan CHF 294.5M 229.5M 2024-06
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
GN Store Nord DKK 1.62B 230M 2024-12
GRIFOLS EUR 269.48M 49.95M 2024-12
Hikma Pharmaceutical USD 280M 4M 2024-06
Merck EUR 1.41B 72M 2024-09
Novartis USD 3.5B 368M 2024-12
Philips EUR 1.33B 99M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
RWE EUR 724M 80M 2024-09
Sanofi EUR 2.68B 26M 2024-09
Smith & Nephew USD 1.35B 12.8M 2024-12



Fresenius Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.